U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Repaglinide

Last Revision: July 15, 2024.

Estimated reading time: 1 minute

CASRN: 135062-02-1

image 135023495 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the use of repaglinide during breastfeeding. Repaglinide is a weak acid that is over 98% protein bound, so it is unlikely to pass into breastmilk in clinically important amounts. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with repaglinide.[1] However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acarbose, Glipizide, Glyburide, Insulin, Metformin, Miglitol

References

1.
Berlin CM, Briggs GG. Drugs and chemicals in human milk. Semin Fetal Neonatal Med 2005;10:149-59 [PubMed: 15701580]

Substance Identification

Substance Name

Repaglinide

CAS Registry Number

135062-02-1

Drug Class

Breast Feeding

Lactation

Milk, Human

Hypoglycemic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501092PMID: 30000151

Views

Related information

Similar articles in PubMed

  • Review Linagliptin.[Drugs and Lactation Database (...]
    Review Linagliptin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Nateglinide.[Drugs and Lactation Database (...]
    Review Nateglinide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Pramlintide.[Drugs and Lactation Database (...]
    Review Pramlintide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Glimepiride.[Drugs and Lactation Database (...]
    Review Glimepiride.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Acetohexamide.[Drugs and Lactation Database (...]
    Review Acetohexamide.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...